ntvh@ariez.nl

HOME
TOTAAL
AML CLINICAL TRIALS GENETICA HEMATOPOIESE IMMUNOLOGIE INNOVATIE LEUKEMIE LYMFOMEN MYELOOM OPINIE ASH TOPPUBLICATIES

Drs. M. van Spronsen

Immunophenotypically aberrant stem cells in myelodysplastic syndromes: a biomarker for leukemic progression